These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3677431)

  • 1. Assay of sodium-lithium countertransport rate by direct measurement of erythrocyte lithium concentrations.
    Siebers RW; Maling TJ
    Clin Chim Acta; 1987 Oct; 168(3):329-36. PubMed ID: 3677431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients.
    Catalano C; Winocour PH; Thomas TH; Walker M; Sum CF; Wilkinson R; Alberti KG
    Diabetologia; 1993 Jan; 36(1):52-6. PubMed ID: 8436253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an altered mode of action of the sodium-lithium countertransporter in vivo in patients with untreated essential hypertension.
    Brearley CJ; Wood AJ; Aronson JK; Grahame-Smith DG
    J Hypertens; 1993 Feb; 11(2):147-53. PubMed ID: 8385174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension.
    Rutherford PA; Thomas TH; Laker MF; Wilkinson R
    Eur J Clin Invest; 1992 Nov; 22(11):719-24. PubMed ID: 1478240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction for the adverse influence of sodium-potassium cotransport on apparent sodium-lithium countertransport activity in human erythrocytes.
    Hardman TC; Morrish Z; Patel M; Chalkley S; Noble MI
    J Pharmacol Toxicol Methods; 2002; 47(1):19-24. PubMed ID: 12387935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated intracellular Ca2+ affects Lii-Nao countertransport in human red blood cells.
    Agam G; Hatzav P; Abekasis S; Loven A; Livne A
    Biochim Biophys Acta; 1987 Nov; 904(2):207-15. PubMed ID: 3663670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of red cell sodium-lithium countertransport measurement--influence of different loading conditions.
    Besch W; Schläger D; Brahm J; Kohnert KD
    Eur J Clin Chem Clin Biochem; 1995 Oct; 33(10):715-9. PubMed ID: 8608193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane in vitro and in vivo sodium-lithium countertransport in New Zealand Maori.
    Maling TJ; van Wissen K; Siebers RW
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):289-91. PubMed ID: 8324911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal variation of erythrocyte sodium-lithium countertransport rate and intracellular cation concentrations.
    Siebers RW; Maling TJ
    Clin Chim Acta; 1990 May; 188(3):227-32. PubMed ID: 2387075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the response of erythrocyte sodium-lithium countertransport to inhibitors.
    Rutherford PA; Thomas TH; Wilkinson R
    Biochem Med Metab Biol; 1993 Apr; 49(2):270-3. PubMed ID: 8484966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the temporal effect of alcohol on human erythrocyte sodium-lithium countertransport in relation to membrane cholesterol and phospholipids.
    Adebayo GI; Gaffney P; Feely J
    Alcohol; 1996; 13(6):597-602. PubMed ID: 8949955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified method for simultaneously determining countertransport and cotransport in human erythrocytes.
    Smith JB; Ash KO; Hentschel WM; Sprowell WL; Williams RR
    Clin Chim Acta; 1984 Feb; 137(2):169-77. PubMed ID: 6705232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the erythrocyte sodium-lithium countertransporter: limitations and assumptions of traditional and kinetic methodologies.
    Hardman TC; Thomas T; Lant AF
    J Membr Biol; 1998 Jan; 161(2):197-205. PubMed ID: 9435275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy.
    Rutherford PA; Thomas TH; Carr SJ; Taylor R; Wilkinson R
    Clin Sci (Lond); 1992 Mar; 82(3):301-7. PubMed ID: 1312415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of significant sodium-hydrogen exchange by rabbit erythrocyte sodium-lithium countertransporter.
    Jennings ML; Adams-Lackey M; Cook KW
    Am J Physiol; 1985 Jul; 249(1 Pt 1):C63-8. PubMed ID: 4014452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-lithium countertransport kinetics in normal and hypertensive human pregnancy.
    Rutherford PA; Thomas TH; MacPhail S; Wilkinson R
    Eur J Clin Invest; 1992 Jan; 22(1):50-4. PubMed ID: 1559543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased erythrocyte sodium-lithium countertransport activity in essential hypertension is due to an increased affinity for extracellular sodium.
    Rutherford PA; Thomas TH; Wilkinson R
    Clin Sci (Lond); 1990 Oct; 79(4):365-9. PubMed ID: 2171857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium activation kinetics of red blood cell Na+/Li+ countertransport in diabetes: methodology and controversy.
    Canessa M; Zerbini G; Laffel LM
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S41-9. PubMed ID: 1457760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modes of operation of an electroneutral Na+/Li+ countertransport in human skin fibroblasts.
    Zerbini G; Mangili R; Gabellini D; Pozza G
    Am J Physiol; 1997 Apr; 272(4 Pt 1):C1373-9. PubMed ID: 9142864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independence of dimethylamiloride-sensitive Li+ efflux pathways and Na+-Li+ countertransport in human erythrocytes.
    Zerbini G; Mangili R; Pozza G
    Biochim Biophys Acta; 1998 Apr; 1371(1):129-33. PubMed ID: 9565666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.